Wang Z, Li Y, Xiao S, Wang Q, Zhang Z, Han F, Huang H. Transcatheter mitral valve-in-valve for pregnancy with anti-phospholipid syndrome: a case report.
J Cardiothorac Surg 2024;
19:335. [PMID:
38898495 PMCID:
PMC11186063 DOI:
10.1186/s13019-024-02702-1]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Accepted: 03/27/2024] [Indexed: 06/21/2024] Open
Abstract
BACKGROUND
Perioperative management and cardiac surgery in pregnant women with anti-phospholipid syndrome combined with heart valve disease have been rarely reported.
CASE PRESENTATION
We describe a case of transcatheter mitral valve-in-valve replacement in a pregnant woman with bioprosthetic valve failure and anti-phospholipid syndrome at 18 weeks' gestation. The patient underwent a cesarean section delivery at 34 weeks of gestation, resulting in the birth of a healthy baby.
CONCLUSIONS
Transapical mitral valve-in-valve surgery resulted in safe maternal and infant outcomes in a pregnant woman with anti-phospholipid syndrome combined with mitral bioprosthetic valve failure. The success of this procedure underscored the importance of multidisciplinary teamwork.
Collapse